News | Conference Coverage | April 20, 2022

ASPC Announces Official Program at Premier Annual Congress on CVD Prevention

The program covers the "ABCs of Preventive Cardiology" over the 2.5 day live, in-person program

The American Society for Preventive Cardiology (ASPC) announces the official program for the ASPC 2022 Congress on CVD Prevention, scheduled July 29-31, 2022 in Louisville, KY.

Pamela S. Douglas, MD, MACC, FASPC


April 20, 2022 – The American Society for Preventive Cardiology (ASPC) announces the official program for the ASPC 2022 Congress on CVD Prevention, scheduled July 29-31, 2022 in Louisville, KY. The program covers the "ABCs of Preventive Cardiology" over the 2.5 day live, in-person program, and can be found on aspconline.org/2022congress.

Included in the 2022 program are a variety of distinguished award lectures including the notable Honorary Fellowship Award and Lecture, honoring Pamela S. Douglas, MD, MACC, FASPC, for her incredible contributions to the field of preventive cardiology. Dr. Douglas will be presenting her lecture entitled "Strengthening CV Prevention for the Future: Beyond the ABCs" on Friday, July 29th during the opening session of the 2022 Congress.

Douglas is the Ursula Geller Professor of Research in Cardiovascular Diseases in the Department of Medicine at Duke University. She has led several landmark multicenter randomized clinical trials and outcomes research studies and is renowned for her scientific and policy work in improving the quality and appropriateness of imaging in clinical care, clinical trials, and registries. Dr Douglas helped to establish several important specialty areas including heart disease in women, sports cardiology, and cardio-oncology.

Other distinguished lecturers, include:

Scott Grundy, MD, PhD will be honored with the Pioneer in Prevention Award on Saturday, July 30th, presenting a lecture on "National Cholesterol Guidelines: 1987-2018". The Pioneer in Prevention Award (previously named Leaders in Medicine) is bestowed on individuals who have profoundly impacted cardiovascular disease prevention by taking the field in a whole new direction.

Also on Saturday, July 30th, Carl J. Pepine, MD, MACC will be honored with the Nanette Wenger Award presenting a lecture on "Open Artery Ischemia: An Unrecognized Opportunity for Prevention?". Dr. Pepine is a Professor and Chief of Cardiovascular Medicine at the University of Florida College of Medicine.

On Sunday, July 31st Donna Arnett, MSPH, PhD will be honored with the Joseph Stokes III, MD Award, presenting "Personalization of Individual Prevention Strategies for Hypertension - Applying '-omics'". Dr. Arnett is Dean of the University of Kentucky College of Public Health and a Professor in the Department of Epidemiology.

The ASPC encourages all to join the world-renowned faculty presenting across the spectrum of preventive cardiology at #ASPC2022 including lectures on cholesterol management for primary CVD prevention, tobacco cessation, barriers associated with the treatment of diabetes, treating obesity as a CV risk factor, open artery ischemia, the role of stress management on CVD, the cardio-renal-metabolic intersection, and an exciting debate about aspirin's role in primary prevention.

Attendees of the 2022 Congress will earn approximately 15 CE/MOC/AAPA credits.

For more information: https://www.aspconline.org/


Related Content

News | Heart Failure

February 15, 2024 — Canary Medical, a medical data company focused on the development and commercialization of its ...

Home February 15, 2024
Home
News | Heart Failure

February 12, 2023 — A team at Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital has successfully ...

Home February 12, 2024
Home
News | Heart Failure

January 30, 2024 — Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a single ...

Home January 30, 2024
Home
News | Heart Failure

January 23, 2024 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

Home January 23, 2024
Home
News | Heart Failure

January 16, 2024 — Cardiac Dimensions, a leader in the development of innovative and minimally invasive treatment ...

Home January 16, 2024
Home
News | Heart Failure

November 30, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home November 30, 2023
Home
News | Heart Failure

November 30, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

Home November 30, 2023
Home
News | Heart Failure

November 16, 2023 — Mount Sinai’s Cardiovascular Research Institute is sending bioengineered human heart muscle cells ...

Home November 16, 2023
Home
News | Heart Failure

November 16, 2023 — A smartphone app using artificial intelligence technology to detect changes in the voice of a person ...

Home November 16, 2023
Home
News | Heart Failure

November 14, 2023 — Deepak Srivastava, MD, president of Gladstone Institutes and a renowned cardiovascular researcher ...

Home November 14, 2023
Home
Subscribe Now